Surgical/Critical Care

ID 184744585 © Jhdt Stock Images Llc | Dreamstime.com
clinical_trial_2
The drug treats hereditary hemorrhagic telangiectasia, which affects every 1 in 3,800 persons and can lead to serious adverse events.
Dec. 10, 2025